Efficacy and tolerability of single agent sorafenib in poor risk advanced hepatocellular carcinoma patients

被引：6
|
作者：
Yau, T. [1 ]
Chan, P. [1 ]
Ng, K. [1 ]
Chok, K. [1 ]
Fan, S. T. [1 ]
Poon, R. [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15513
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Wong, H.
    Yau, C. C.
    Yao, T.
    Tang, V.
    Chan, P.
    Chiu, J.
    Fan, S.
    Peon, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Tolerability of Single-Agent Sorafenib in the Treatment of Elderly Patients With Hepatocellular Carcinoma (HCC)
    Francini, Edoardo
    Bianco, Vincenzo
    [J]. HEPATOLOGY, 2014, 60 (02) : 764 - 765
  • [3] Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
    Kostner, Anne Helene
    Sorensen, Morten
    Olesen, Rene Krojgaard
    Gronbaek, Henning
    Lassen, Ulrik
    Ladekarl, Morten
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [4] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Masayoshi Yada
    Akihide Masumoto
    Kenta Motomura
    Hirotaka Tajiri
    Yusuke Morita
    Hideo Suzuki
    Takeshi Senju
    Toshimasa Koyanagi
    [J]. World Journal of Gastroenterology, 2014, (35) : 12581 - 12587
  • [5] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Yada, Masayoshi
    Masumoto, Akihide
    Motomura, Kenta
    Tajiri, Hirotaka
    Morita, Yusuke
    Suzuki, Hideo
    Senju, Takeshi
    Koyanagi, Toshimasa
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12581 - 12587
  • [6] Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Marta, Guilherme Nader
    da Fonseca, Leonardo G.
    Braghiroli, Maria Ignez
    Moura, Fernando
    Hoff, Paulo M.
    Sabbaga, Jorge
    [J]. CLINICS, 2021, 76 : 1 - 6
  • [7] Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma
    Santini, Daniele
    Addeo, Raffaele
    Vincenzi, Bruno
    Calvieri, Alice
    Montella, Liliana
    Silletta, Marianna
    Caraglia, Michele
    Vespasiani, Umberto
    Picardi, Antonio
    Del Prete, Salvatore
    Tonini, Giuseppe
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1283 - 1288
  • [8] SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: EXPERIENCE IN SINGLE INSTITUTE
    Lee, S. S.
    Chang, H. M.
    Lee, J.
    Kim, T. W.
    Kim, K. M.
    Lee, H. C.
    Lee, Y. S.
    Suh, D. J.
    Lee, S. G.
    Kang, Y.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 179 - 179
  • [9] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [10] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
    Ziogas, Dimitrios C.
    Papadatos-Pastos, Dionysios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, Ruhe
    Suddle, Abid
    O'Grady, John
    Al-Khadimi, Gillian
    Allen, Natalie
    Heaton, Nigel
    Ross, Paul J.
    Sarkera, Debashis
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (01) : 48 - 55
12345